[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","course_id":"PHMSCI 640","course_uid":"course_6f31cad7c7eda11ec2443b72","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","course_number":640,"subjects":["PHMSCI"],"title":"APPROPRIATE USE OF ABUSED DRUGS","description":"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents. Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances. Includes therapeutic tapering, withdrawal management, overdose treatment, interpretation of urine drug tests, and use of prescription drug monitoring programs. Not open to students with credit for PHARMACY 640 prior to fall 2026.","requirements_text":"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","course_id":"PHMSCI 640","course_uid":"course_6f31cad7c7eda11ec2443b72","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","course_number":640,"subjects":["PHMSCI"],"title":"APPROPRIATE USE OF ABUSED DRUGS","description":"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents. Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances. Includes therapeutic tapering, withdrawal management, overdose treatment, interpretation of urine drug tests, and use of prescription drug monitoring programs. Not open to students with credit for PHARMACY 640 prior to fall 2026.","requirements_text":"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation"}]